Vera Therapeutics, Inc. VERA
Set alert
30.75 USD +0.50 +1.65%
As of Nov 3, 11:32 AM ET
29.90 Day range 31.07
23.05 52-week range 56.05
- YTD
- -39.28%
- 1 year
- +18.54%
- Open
- 30.26
- Prev close
- 30.25
- Mkt cap
- 2.22B
- Vol
- 464.77K
- Avg vol
- 2.14M
- EPS
- -5.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.90
- High
- 31.07
- Forward P/E
- -7.12
- Beta
- 1.19
- Short ratio
- 5.52
- Inst. own
- 117.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 32.00
- 200-d avg
- 36.96
- 1y target
- 74.20
MAX chart
Events in this range
- Aug 5, 2025Earnings: -1.2; estimate -0.82; surprise -46.34%
- Nov 5, 2025Earnings: -1.26; estimate -1.2; surprise -5%
- Feb 26, 2026Earnings: -1.39; estimate -1.34; surprise -3.73%
- May 7, 2026Earnings: -1.69; estimate -1.32838; surprise -27.22%
- Jul 8, 2026Rating: TD Cowen · Buy → Buy
- Aug 10, 2026Earnings: -1.52; estimate -1.58; surprise 3.8%
- Aug 11, 2026Rating: Wedbush · Neutral → Neutral
- Aug 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 17, 2026Rating: Wedbush · Neutral → Neutral
- Sep 8, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 12, 2026Rating: Leerink Partners · — → Market Perform
- Nov 5, 2026Earnings: —; estimate -1.62; surprise —%
Signals (99)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| RSI: Overbought | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
Newest 20 of 99.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 74.20 +141.3% upside
Now 30.75
- Target (low)
- 34.00
- Target (mean)
- 74.20
- Target (high)
- 100.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
- Strong buy1
- Buy12
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.61 | -1.80 – -1.39 | -1.26 | -27.6% | 3.74M | 0.0% | 9 |
| Next quarter | -1.54 | -2.18 – -1.21 | -1.39 | -10.9% | 17.44M | 0.0% | 9 |
| Current year | -6.25 | -7.23 – -5.77 | -4.66 | -34.2% | 24.83M | 0.0% | 10 |
| Next year | -4.25 | -6.72 – -2.23 | -6.25 | +32.0% | 233.76M | +841.4% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | Initiated | — | Market Perform |
| Sep 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 17, 2026 | Wedbush | Reiterated | Neutral | Neutral |
| Aug 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jul 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 8, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 8, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jul 8, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 15, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 11, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 19, 2025 | B of A Securities | Maintained | Buy | Buy |
| Dec 19, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Dec 19, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Dec 11, 2025 | Wedbush | Maintained | Neutral | Neutral |
| Dec 8, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Dec 5, 2025 | TD Cowen | Maintained | Buy | Buy |
| Nov 10, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 7, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 16, 2025 | B of A Securities | Initiated | — | Buy |
| Aug 7, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 4, 2025 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Jun 2, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Jun 2, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 12, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| May 7, 2025 | Wedbush | Maintained | Neutral | Neutral |
| May 7, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Mar 4, 2025 | JP Morgan | Maintained | Overweight | Overweight |